CH621874A5 - Diagnostic composition and process for its preparation - Google Patents

Diagnostic composition and process for its preparation Download PDF

Info

Publication number
CH621874A5
CH621874A5 CH944975A CH944975A CH621874A5 CH 621874 A5 CH621874 A5 CH 621874A5 CH 944975 A CH944975 A CH 944975A CH 944975 A CH944975 A CH 944975A CH 621874 A5 CH621874 A5 CH 621874A5
Authority
CH
Switzerland
Prior art keywords
gel
erythrocytes
diagnostic agent
virus
agent according
Prior art date
Application number
CH944975A
Other languages
German (de)
English (en)
Inventor
Stuart Millar Russell
Leonard William Jerome Bishop
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of CH621874A5 publication Critical patent/CH621874A5/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/554—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
    • G01N33/555—Red blood cell
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • G01N33/559—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody through a gel, e.g. Ouchterlony technique
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dispersion Chemistry (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CH944975A 1974-07-19 1975-07-18 Diagnostic composition and process for its preparation CH621874A5 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB32050/74A GB1501395A (en) 1974-07-19 1974-07-19 Viral anti-body detection

Publications (1)

Publication Number Publication Date
CH621874A5 true CH621874A5 (en) 1981-02-27

Family

ID=10332393

Family Applications (1)

Application Number Title Priority Date Filing Date
CH944975A CH621874A5 (en) 1974-07-19 1975-07-18 Diagnostic composition and process for its preparation

Country Status (21)

Country Link
JP (1) JPS5135418A (fi)
AT (1) AT352289B (fi)
AU (1) AU500101B2 (fi)
BE (1) BE831554A (fi)
BR (1) BR7504584A (fi)
CA (1) CA1054935A (fi)
CH (1) CH621874A5 (fi)
DE (1) DE2532283A1 (fi)
DK (1) DK328075A (fi)
ES (1) ES439520A1 (fi)
FI (1) FI752081A (fi)
FR (1) FR2278308A1 (fi)
GB (1) GB1501395A (fi)
IE (1) IE41633B1 (fi)
IL (1) IL47736A (fi)
IT (1) IT1048304B (fi)
NL (1) NL7508624A (fi)
NO (1) NO752568L (fi)
NZ (1) NZ178160A (fi)
SE (1) SE7508228L (fi)
ZA (1) ZA754643B (fi)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1146852A (en) * 1979-01-31 1983-05-24 Koichi Kondo Reagent for latex agglutination

Also Published As

Publication number Publication date
FR2278308B1 (fi) 1979-03-09
ATA558875A (de) 1979-02-15
FR2278308A1 (fr) 1976-02-13
AT352289B (de) 1979-09-10
NO752568L (fi) 1976-01-20
IE41633L (en) 1976-01-19
AU500101B2 (en) 1979-05-10
NZ178160A (en) 1978-06-20
DE2532283A1 (de) 1976-01-29
ES439520A1 (es) 1977-04-01
IL47736A0 (en) 1975-10-15
SE7508228L (sv) 1976-01-20
BR7504584A (pt) 1976-07-06
CA1054935A (en) 1979-05-22
ZA754643B (en) 1977-02-23
FI752081A (fi) 1976-01-20
JPS5135418A (fi) 1976-03-25
IT1048304B (it) 1980-11-20
IL47736A (en) 1978-07-31
IE41633B1 (en) 1980-02-13
GB1501395A (en) 1978-02-15
DK328075A (da) 1976-01-20
AU8317575A (en) 1977-01-20
NL7508624A (nl) 1976-01-21
BE831554A (fr) 1976-01-19

Similar Documents

Publication Publication Date Title
DE2551208A1 (de) Stabile erythrozyten-praeparation, verfahren zu deren herstellung und deren verwendung
DE2322562C2 (de) Verfahren zur Bestimmung von Antigenen in einer Probe
DE69716046T2 (de) Methode zur erkennung von heparin-induzierter thrombozytopenie
DE1598832A1 (de) Auf der Beobachtung eines Agglutinationsvorganges beruhendes Verfahren zum Nachweis von Choriongonadotropin in Koerperfluessigkeiten
EP0058780A1 (de) Antigen/Antikörper-Bestimmungsmethode
DE2900546B2 (de) Verfahren zum Standardisieren einer markierten Bindungskomponente, welche in einem spezifischen Bindungstest-Verfahren mit einem Liganden reagiert, gegen einen Liganden-Referenzstandard und Verwendung der standardisierten markierten Bindungskomponente in spezifischen Bindungstest-Verfahren
DE2403994A1 (de) Herstellung von antisera
DE2037507A1 (fi)
DE3434082A1 (de) Wasserunloesliche zubereitung von hyaluronsaeure
DE2714751C2 (fi)
DE2934756A1 (de) Zusammensetzung zur bestimmung von beta 2 -humanmikroglobulin und verfahren zu deren herstellung und deren verwendung
CH621874A5 (en) Diagnostic composition and process for its preparation
DE2850950B2 (de) Verwendung von nativem oder thermisch modifiziertem Cytochrom c als Stabilisator für ein immunochemisches Meßreagens, immunochemisches Meflreagens sowie Pufferlösung zur Probenverdünnung bei immunchemischen Meßverfahren
DE2025718C3 (de) Verfahren zum Stabilisieren von lyophillsierten Erythrozyten
DE3424640A1 (de) Verfahren zur gewinnung und/oder bestimmung von humanspezifischem interferon im blut
DE2814121C3 (de) Verfahren zur Herstellung eines bei der Krebs-Diagnose verwendbaren spezifischen Immunserums K K Saikin Kagaku Kenkyujo, Sendaishi
DE2126128A1 (de) Medizinisches Testverfahren, Reagens und Additiv zur Durchführung des Verfahrens
DE1954728C3 (de) Pufferlösung zur Verwendung in einem Hämagglutinationstest
DE69317931T2 (de) Sensibilisierte Erythrozyten, ein Verfahren zu deren Herstellung, und deren Verwendung
DE68912772T2 (de) Monoklonaler antikörper gegen entero-viren.
DE3024270A1 (de) Masse zur bestimmung von menschlichem erythropoietin und deren anwendung
DE2555188C2 (de) Verfahren zum Nachweis von Antigen oder Antikörper von infektiöser Hepatitis A in einer Probe
DE3112334A1 (de) "kuenstliche kontroll- und standardseren, verfahren zu ihrer herstellung und ihre verwendung"
EP0013306B1 (de) Verfahren zur Bestimmung eines opsonierenden oberflächenbindenden alpha-2-Glykoproteins
DE3119269A1 (de) Verfahren zur bestimmung der zellvermittelten reaktivitaet

Legal Events

Date Code Title Description
PL Patent ceased